Clover Health Investments and Outset Medical Compared in Critical Survey

Analysts see Outset Medical as the more favorable stock over Clover Health Investments

Published on Feb. 28, 2026

Got story updates? Submit your updates here. ›

A critical survey compares two small-cap medical companies, Outset Medical (NASDAQ:OM) and Clover Health Investments (NASDAQ:CLOV), to determine which is the better business. The analysis looks at factors like net margins, return on equity, revenue, earnings per share, valuation, and analyst recommendations.

Why it matters

The comparison of these two healthcare companies provides investors with insights into the relative strengths and weaknesses of each firm, helping them make more informed decisions about where to allocate their capital in the medical technology and services sector.

The details

The analysis finds that Outset Medical has a stronger consensus rating from analysts and higher potential upside, despite Clover Health Investments having higher revenue and earnings. Clover Health Investments scores better on 10 out of 15 factors compared, but Outset Medical is seen as the more favorable stock overall.

  • The analysis was published on February 20, 2026.

The players

Outset Medical, Inc.

A medical technology company that develops and manufactures the Tablo Hemodialysis System for acute and home dialysis care.

Clover Health Investments, Corp.

A provider of Medicare Advantage plans in the United States, operating in the Insurance and Non-Insurance segments.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the relative strengths and weaknesses of two small-cap medical companies, providing investors with valuable insights to consider when evaluating potential investments in the healthcare sector.